Healthcare provider profile · identity verified

Andrew I Wolff, MD

Internal Medicine · ROCHESTER, NY · NPI 1609979509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	874	250
Amlodipine Besylate	Amlodipine Besylate	472	120
Levothyroxine Sodium	Levothyroxine Sodium	390	91
Lisinopril	Lisinopril	334	82
Losartan Potassium	Losartan Potassium	311	79
Gabapentin	Gabapentin	309	72
Rosuvastatin Calcium	Rosuvastatin Calcium	239	58
Omeprazole	Omeprazole	228	53
Hydrochlorothiazide	Hydrochlorothiazide	218	64
Famotidine	Famotidine	199	63
Metoprolol Succinate	Metoprolol Succinate	196	55
Pantoprazole Sodium	Pantoprazole Sodium	165	50
Sertraline Hcl	Sertraline Hcl	150	45
Metformin Hcl	Metformin Hcl	149	41
Duloxetine Hcl	Duloxetine Hcl	145	30
Metformin Hcl Er	Metformin Hcl	145	41
Alendronate Sodium	Alendronate Sodium	138	26
Simvastatin	Simvastatin	132	35
Metoprolol Tartrate	Metoprolol Tartrate	124	26
Chlorthalidone	Chlorthalidone	119	30
Albuterol Sulfate Hfa	Albuterol Sulfate	99	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	26
Tamsulosin Hcl	Tamsulosin Hcl	94	24
Bupropion Xl	Bupropion Hcl	93	18
Eliquis	Apixaban	92	25
Zolpidem Tartrate	Zolpidem Tartrate	86	17
Meloxicam	Meloxicam	85	30
Valsartan	Valsartan	78	25
Allopurinol	Allopurinol	75	23
Torsemide	Torsemide	75	23
Furosemide	Furosemide	73	21
Tramadol Hcl	Tramadol Hcl	71	12
Ozempic	Semaglutide	70	15
Fluoxetine Hcl	Fluoxetine Hcl	67	17
Fluticasone Propionate	Fluticasone Propionate	67	27
Trazodone Hcl	Trazodone Hcl	65	15
Pravastatin Sodium	Pravastatin Sodium	63	20
Jardiance	Empagliflozin	60	18
Escitalopram Oxalate	Escitalopram Oxalate	58	13
Spironolactone	Spironolactone	52	16
Irbesartan	Irbesartan	51	14
Montelukast Sodium	Montelukast Sodium	47	12
Alprazolam	Alprazolam	46	23
Ezetimibe	Ezetimibe	46	suppressed
Trulicity	Dulaglutide	46	suppressed
Carvedilol	Carvedilol	44	12
Oxycodone Hcl	Oxycodone Hcl	44	13
Prednisone	Prednisone	44	31
Verapamil Er	Verapamil Hcl	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	12
Synthroid	Levothyroxine Sodium	42	12
Venlafaxine Hcl Er	Venlafaxine Hcl	42	11
Doxycycline Hyclate	Doxycycline Hyclate	41	36
Hydroxyzine Hcl	Hydroxyzine Hcl	41	12
Lorazepam	Lorazepam	41	11
Atenolol	Atenolol	39	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	18
Mirtazapine	Mirtazapine	39	suppressed
Cephalexin	Cephalexin	36	28
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Felodipine Er	Felodipine	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	11
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	13
Xarelto	Rivaroxaban	34	suppressed
Celecoxib	Celecoxib	33	12
Clonazepam	Clonazepam	32	11
Potassium Chloride	Potassium Chloride	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	30	suppressed
Lansoprazole	Lansoprazole	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	19
Ibuprofen	Ibuprofen	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Finasteride	Finasteride	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Invokana	Canagliflozin	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Methylprednisolone	Methylprednisolone	22	21
Ramipril	Ramipril	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Eplerenone	Eplerenone	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Diazepam	Diazepam	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Azithromycin	Azithromycin	18	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Amoxicillin	Amoxicillin	17	13
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Baclofen	Baclofen	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Methimazole	Methimazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error